Luminoma
Auckland, NZ · 3 known investors
Find your way into Luminoma
109 people in our graph share verified history with the Luminoma team — schools, employers, funds. One of them is your warm intro.
Avantika Guptaunlockedknows Michel Nieuwoudt · together at The University of Auckland (overlapped)
knows the team · via The University of Auckland
×2knows the team · via Council for Scientific and Industrial Research (CSIR)
×8knows the team · via Pacific Channel
Luminoma is developing the LumAssure, a portable diagnostic-aid that uses Raman spectroscopy to non-invasively assess whether a skin lesion is likely malignant or benign within seconds. The device is intended to help clinicians make more objective skin cancer biopsy decisions and reduce unnecessary biopsies.
Founders & leadership
CS
MN
Michel NieuwoudtinChief Scientific OfficerMichel Nieuwoudt is Chief Scientific Officer at Luminoma, where he leads development of portable spectroscopic diagnostic systems. He has expertise in Raman and FTIR spectroscopy, chemometrics, and materials science, with a focus on applying vibrational spectroscopy methods to clinical applications including skin disease monitoring.
Investors · 3
Frequently asked questions
- What does Luminoma do?
- Luminoma is developing the LumAssure, a portable diagnostic-aid that uses Raman spectroscopy to non-invasively assess whether a skin lesion is likely malignant or benign within seconds. The device is intended to help clinicians make more objective skin cancer biopsy decisions and reduce unnecessary biopsies.
- Who founded Luminoma?
- Luminoma was founded by Cather Simpson.
- Who are Luminoma's investors?
- Luminoma's investors include Angel HQ, Bridgewest Ventures, Pacific Channel.
- Where is Luminoma headquartered?
- Luminoma is headquartered in Auckland, NZ.